Bacillus Calmette-Guérin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression.

@article{Andius2004BacillusCT,
  title={Bacillus Calmette-Gu{\'e}rin therapy in stage Ta/T1 bladder cancer: prognostic factors for time to recurrence and progression.},
  author={Patrik Andius and Sten Holm{\"a}ng},
  journal={BJU international},
  year={2004},
  volume={93 7},
  pages={980-4}
}
OBJECTIVE To report prognostic factors for time to recurrence and progression after bacillus Calmette-Guérin (BCG) prophylaxis in patients with stage Ta/T1 papillary bladder cancer. PATIENTS AND METHODS The clinical records were assessed retrospectively for 236 patients with papillary stage Ta/T1 bladder cancer treated with BCG between 1986 and 2000. Patients with known carcinoma in situ were excluded. The median (range) follow-up was 44 (4-155) months. The effect of 13 variables on the time… CONTINUE READING